Life Sciences Solutions — Restructuring and other costs

Business Segments · Restructuring and other costs

Thermo Fisher Scientific Life Sciences Solutions — Restructuring and other costs increased by 352.2% to $78.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 352.2%, from $17.25M to $78.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2025

How to read this metric

High costs may indicate active operational improvement efforts, while consistently high levels could suggest ongoing integration challenges.

Detailed definition

Expenses incurred by the Life Sciences Solutions segment related to organizational changes, such as facility consolidati...

Peer comparison

Commonly reported by large, acquisitive firms undergoing periodic operational optimization.

Metric ID: tmo_segment_life_sciences_solutions_restructuring_and_other_costs

Historical Data

11 periods
 Q1 '22Q2 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q3 '25
Value$1.00M$5.00M$26.25M$26.25M$26.25M$26.25M$17.25M$17.25M$17.25M$17.25M$78.00M
QoQ Change+400.0%+425.0%+0.0%+0.0%+0.0%-34.3%+0.0%+0.0%+0.0%+352.2%
YoY Change>999%+425.0%-34.3%-34.3%-34.3%-34.3%+352.2%
Range$1.00M$78.00M
CAGR+471.3%
Avg YoY Growth+452.1%
Median YoY Growth-34.3%
Current Streak4 quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's life sciences solutions — restructuring and other costs?
Thermo Fisher Scientific (TMO) reported life sciences solutions — restructuring and other costs of $78.00M in Q3 2025.
How has Thermo Fisher Scientific's life sciences solutions — restructuring and other costs changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — restructuring and other costs increased by 352.2% year-over-year, from $17.25M to $78.00M.
What does life sciences solutions — restructuring and other costs mean?
One-time costs associated with reorganizing or streamlining the life sciences business operations.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.